Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of Nottingham
Age
18–75
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Age 18-75 of either sex with a clinical diagnosis of asthma,
FEV1 ≥ 60% predicted and an increase in FEV1 of greater than 12% following inhaled salbutamol 400μg or Peak Expiratory Flow (PEF) variability \>12% during run-in.
Allowed medication: 0-800μg inhaled beclomethasone diproprionate or equivalent and as required short acting beta agonist.
You may not be if
Current smoking,
\> 10 pack years smoking history,
Treatment with leukotriene antagonists,
Liver or cardiovascular disease,
Oral steroid treatment or exacerbation within 6 weeks,
Females who are pregnant, lactating or not using adequate contraception,
Any contra-indication to pioglitazone (hypersensitivity to pioglitazone, cardiac failure, history of cardiac failure, hepatic impairment, diabetic ketoacidosis),